Rapid Determination of Dapagliflozin in Rat Plasma by UHPLC-Q-Orbitrap MS and Its Application to a Pharmacokinetic Study
Chemical and Pharmaceutical Bulletin · 2023
DOI: 10.1248/cpb.c22-00843 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemical and Pharmaceutical Bulletin, 2023. Verfasst von Lin-Jiao Wang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Hai'an Hospital Affiliated to Nantong University. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 31 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology, Hai'an Hospital Affiliated to Nantong University.
Zitieren
APA
Wang, L. J., Xi, W., Yuan, X. L., & Yang, X. H. (2023). Rapid Determination of Dapagliflozin in Rat Plasma by UHPLC-Q-Orbitrap MS and Its Application to a Pharmacokinetic Study. Chemical and Pharmaceutical Bulletin. https://doi.org/10.1248/cpb.c22-00843
Vancouver
Wang LJ, Xi W, Yuan XL, Yang XH. Rapid Determination of Dapagliflozin in Rat Plasma by UHPLC-Q-Orbitrap MS and Its Application to a Pharmacokinetic Study. Chemical and Pharmaceutical Bulletin. 2023. doi:10.1248/cpb.c22-00843
BibTeX
@article{Wang2023,
author = {Wang, Lin-Jiao and Xi, Wei and Yuan, Xiao-Lan and Yang, Xiao-Hua},
title = {Rapid Determination of Dapagliflozin in Rat Plasma by UHPLC-Q-Orbitrap MS and Its Application to a Pharmacokinetic Study},
journal = {Chemical and Pharmaceutical Bulletin},
year = {2023},
doi = {10.1248/cpb.c22-00843}
}
EUVIMED